Granulocyte macrophage colony-stimulating factor is the main cytokine enhancing survival of eosinophils in asthmatic airways

Interleukin (IL)-3, IL-5 and granulocyte macrophage colony-stimulating factor (GM-CSF) prolong the survival of eosinophils, which are conspicuous in asthmatic airways, but it is still controversial which one plays a major role in enhancing the survival of eosinophils in asthmatic airways. The role of these cytokines in airway eosinophilia was investigated using bronchoalveolar lavage (BAL) fluids from 11 symptomatic and nine asymptomatic patients with asthma and eight normal subjects. Eosinophil survival-enhancing activity (ESEA) was measured by a numerical change in viable eosinophils isolated from the peripheral blood of atopic patients and cultured with BAL fluids. ESEA was characterized by neutralization with antibodies to IL-3, IL-5 and/or GM-CSF. The differential count of BAL cells was achieved using Diff-Quik stain. T-cell subsets and activated T-cells were analysed by flow cytometry with dual stain using monoclonal antibodies to CD3, CD4, CD8 and CD25. ESEA was detected in eight of 11 BAL fluids of symptomatic asthma, but not in those of normal controls or asymptomatic asthmatics. In six symptomatic asthmatics, the mean percentage of inhibition in ESEA by anti-GM-CSF was higher than that of anti-IL-5 as well as anti-IL-3 (p<0.05). A mixture of antibodies to IL-3, IL-5 and GM-CSF totally inhibited the ESEA in four cases. The ESEA correlated with the percentage of eosinophils (p<0.05) and that of CD25(+)CD4 lymphocytes (p<0.05) of BAL cells. In conclusion, granulocyte macrophage colony-stimulating factor, rather than interleukin-3 or -5, is associated with eosinophil survival-enhancing activity inside the airways of symptomatic asthmatics. The activation of CD4 lymphocytes is related to the elevation of such activity.

This article has been cited by other articles:

				K. Pazdrak, T. W. Young, S. Stafford, B. Olszewska-Pazdrak, C. Straub, V. Starosta, A. Brasier, and A. Kurosky Cross-Talk between ICAM-1 and GM-CSF Receptor Signaling Modulates Eosinophil Survival and Activation J. Immunol., March 15, 2008; 180(6): 4182 - 4190. [Abstract] [Full Text] [PDF]

				J. Loven, N. Svitacheva, A. Jerre, A. Miller-Larsson, and S. H. Korn Anti-inflammatory activity of {beta}2-agonists in primary lung epithelial cells is independent of glucocorticoid receptor Eur. Respir. J., November 1, 2007; 30(5): 848 - 856. [Abstract] [Full Text] [PDF]

				P. M. O'Byrne Cytokines or their antagonists for the treatment of asthma. Chest, July 1, 2006; 130(1): 244 - 250. [Abstract] [Full Text] [PDF]

				M. Tsoumakidou, E. Papadopouli, N. Tzanakis, and N. M. Siafakas Airway Inflammation and Cellular Stress in Noneosinophilic Atopic Asthma Chest, May 1, 2006; 129(5): 1194 - 1202. [Abstract] [Full Text] [PDF]

				B. N. Chorley, Y. Li, S. Fang, J.-A. Park, and K. B. Adler (R)-Albuterol Elicits Antiinflammatory Effects in Human Airway Epithelial Cells via iNOS Am. J. Respir. Cell Mol. Biol., January 1, 2006; 34(1): 119 - 127. [Abstract] [Full Text] [PDF]

				M. Tsoumakidou, N. Tzanakis, G. Chrysofakis, and N. M. Siafakas Nitrosative Stress, Heme Oxygenase-1 Expression and Airway Inflammation During Severe Exacerbations of COPD Chest, June 1, 2005; 127(6): 1911 - 1918. [Abstract] [Full Text] [PDF]

				P. B. Stamatiou, C.-C. Chan, G. Monneret, D. Ethier, J. Rokach, and W. S. Powell 5-Oxo-6,8,11,14-eicosatetraenoic Acid Stimulates the Release of the Eosinophil Survival Factor Granulocyte/Macrophage Colony-stimulating Factor from Monocytes J. Biol. Chem., July 2, 2004; 279(27): 28159 - 28164. [Abstract] [Full Text] [PDF]

				M. E. Bates, L. Y. Liu, S. Esnault, B. A. Stout, E. Fonkem, V. Kung, J. B. Sedgwick, E. A. B. Kelly, D. M. Bates, J. S. Malter, et al. Expression of Interleukin-5- and Granulocyte Macrophage-Colony-Stimulating Factor-Responsive Genes in Blood and Airway Eosinophils Am. J. Respir. Cell Mol. Biol., May 1, 2004; 30(5): 736 - 743. [Abstract] [Full Text] [PDF]

				W. T. Gerthoffer and C. A. Singer Secretory Functions of Smooth Muscle: Cytokines and Growth Factors Mol. Interv., November 1, 2002; 2(7): 447 - 456. [Abstract] [Full Text] [PDF]

				M. T. Borchers, P. J. Justice, T. Ansay, V. Mancino, M. P. McGarry, J. Crosby, M. I. Simon, N. A. Lee, and J. J. Lee Gq Signaling Is Required for Allergen-Induced Pulmonary Eosinophilia J. Immunol., April 1, 2002; 168(7): 3543 - 3549. [Abstract] [Full Text] [PDF]

				S. Page, A. J. Ammit, J. L. Black, and C. L. Armour Human mast cell and airway smooth muscle cell interactions: implications for asthma Am J Physiol Lung Cell Mol Physiol, December 1, 2001; 281(6): L1313 - L1323. [Abstract] [Full Text] [PDF]

				S. Esnault and J. S. Malter Granulocyte Macrophage-Colony-Stimulating Factor mRNA Is Stabilized in Airway Eosinophils and Peripheral Blood Eosinophils Activated by TNF-{{alpha}} Plus Fibronectin J. Immunol., April 1, 2001; 166(7): 4658 - 4663. [Abstract] [Full Text] [PDF]

				S. P. Sanders, J. Kim, K. Ryan Connolly, J. D. Porter, E. S. Siekierski, and D. Proud Nitric Oxide Inhibits Rhinovirus-Induced Granulocyte Macrophage Colony-Stimulating Factor Production in Bronchial Epithelial Cells Am. J. Respir. Cell Mol. Biol., March 1, 2001; 24(3): 317 - 325. [Abstract] [Full Text] [PDF]

				E. LEE, T. ROBERTSON, J. SMITH, and S. KILFEATHER Leukotriene Receptor Antagonists and Synthesis Inhibitors Reverse Survival in Eosinophils of Asthmatic Individuals Am. J. Respir. Crit. Care Med., June 1, 2000; 161(6): 1881 - 1886. [Abstract] [Full Text]

				C. E. Donovan, D. A. Mark, H. Z. He, H.-C. Liou, L. Kobzik, Y. Wang, G. T. De Sanctis, D. L. Perkins, and P. W. Finn NF-{kappa}B/Rel Transcription Factors: c-Rel Promotes Airway Hyperresponsiveness and Allergic Pulmonary Inflammation J. Immunol., December 15, 1999; 163(12): 6827 - 6833. [Abstract] [Full Text] [PDF]

				K F Chung and P J Barnes Cytokines in asthma Thorax, September 1, 1999; 54(9): 825 - 857. [Full Text]